Please turn JavaScript on

Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.15 / day

Message History

Can dietary fiber outperform one of the most widely prescribed diabetes medications? A small randomized trial raises that possibility, but its findings require careful interpretation. In a clinical trial comparing a high-fiber diet with metformin, participants following the dietary intervention experienced greater improvements in A1C and body mass index (BMI). However, the st...


Read full story

A child may recover from diabetic ketoacidosis (DKA) or hypoglycemia, but could differences in attention remain? New research suggests that children with type 1 diabetes may experience differences in attention and cognitive performance associated with previous metabolic complications. Published in Endocrine in October 2026, the study found that clinically significant hypoglyc...


Read full story

Metformin is widely used to manage type 2 diabetes and is sometimes prescribed during pregnancy. However, questions remain about its long-term effects on children exposed before birth. A new population-based study offers important insights into how metformin use during pregnancy may affect child development, examining physical, emotional, social, and learning abilities years ...


Read full story

Managing insulin during parenteral nutrition becomes especially challenging when patients receive nutrients overnight but need steady glucose control throughout the day. Unlike regular meals, nocturnal parenteral nutrition delivers glucose directly into the bloodstream for several hours. As a result, insulin needs can rise sharply during feeding and fall when the infusion sto...


Read full story

Could a medication traditionally prescribed to lower triglycerides also protect the eyes of people with type 1 diabetes? New research is bringing that possibility closer to clinical discussion. The potential role of fenofibrate in slowing diabetic retinopathy among people with type 1 diabetes has gained attention following a new analysis of the randomized LENS trial, publishe...


Read full story